Literature DB >> 25207215

Parathyroid carcinoma: a silent presentation.

Sangeetha Kolluri1, Karan Lal1, Robert Chang1, Nageswara Mandava1.   

Abstract

Primary hyperparathyroidism is most commonly diagnosed in the setting of benign parathyroid adenoma(s). However, it can also rarely be caused by parathyroid malignancy and when it is, the clinical manifestations far supercede the presentation of benign parathyroid adenoma. We report a case of suspected benign parathyroid adenoma induced primary hyperparathyroidism in which pathologic diagnosis of parathyroid carcinoma was made. Due to the lack of signs and symptoms, this indicates parathyroid malignancy can be masked clinically as benign adenomas, until a histologic diagnosis can be ascertained.

Entities:  

Keywords:  Hyperparathyroidism; mutation; parathyroid

Year:  2014        PMID: 25207215      PMCID: PMC4139129          DOI: 10.3978/j.issn.2227-684X.2014.07.02

Source DB:  PubMed          Journal:  Gland Surg        ISSN: 2227-684X


  22 in total

Review 1.  Clinical review 122: Parathyroid carcinoma.

Authors:  E Shane
Journal:  J Clin Endocrinol Metab       Date:  2001-02       Impact factor: 5.958

2.  Hyperparathyroidism-jaw tumor syndrome.

Authors:  Matthew R Kutcher; Matthew H Rigby; Martin Bullock; Jonathan Trites; S Mark Taylor; Robert D Hart
Journal:  Head Neck       Date:  2012-02-02       Impact factor: 3.147

3.  Parathyroid carcinoma.

Authors:  A Dilli; S S Gultekin; U Y Ayaz; S Ayaz
Journal:  JBR-BTR       Date:  2013 Jul-Aug

Review 4.  Parathyroid pathology: hyperparathyroidism and parathyroid tumors.

Authors:  Diane Carlson
Journal:  Arch Pathol Lab Med       Date:  2010-11       Impact factor: 5.534

5.  Parathyroid carcinoma. A study of 70 cases.

Authors:  A Schantz; B Castleman
Journal:  Cancer       Date:  1973-03       Impact factor: 6.860

6.  HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome.

Authors:  J D Carpten; C M Robbins; A Villablanca; L Forsberg; S Presciuttini; J Bailey-Wilson; W F Simonds; E M Gillanders; A M Kennedy; J D Chen; S K Agarwal; R Sood; M P Jones; T Y Moses; C Haven; D Petillo; P D Leotlela; B Harding; D Cameron; A A Pannett; A Höög; H Heath; L A James-Newton; B Robinson; R J Zarbo; B M Cavaco; W Wassif; N D Perrier; I B Rosen; U Kristoffersson; P D Turnpenny; L-O Farnebo; G M Besser; C E Jackson; H Morreau; J M Trent; R V Thakker; S J Marx; B T Teh; C Larsson; M R Hobbs
Journal:  Nat Genet       Date:  2002-11-18       Impact factor: 38.330

7.  Localization and reoperation results for persistent and recurrent parathyroid carcinoma.

Authors:  E Kebebew; C Arici; Q Y Duh; O H Clark
Journal:  Arch Surg       Date:  2001-08

8.  Familial hyperparathyroidism: surgical outcome after 30 years of follow-up in three families with germline HRPT2 mutations.

Authors:  Marta S Sarquis; Leticia G Silveira; Flavio J Pimenta; Eduardo P Dias; Bin T Teh; Eitan Friedman; Ricardo S Gomez; Gabriela C Tavares; Charis Eng; Luiz De Marco
Journal:  Surgery       Date:  2008-03-17       Impact factor: 3.982

9.  The unequal distribution of parathyroid neoplasms in male patients.

Authors:  Bryan Goldner; Byrne Lee; Bruce E Stabile
Journal:  Am Surg       Date:  2013-10       Impact factor: 0.688

10.  Intraoperative parathyroid hormone level in parathyroidectomy: which patients benefit from it?

Authors:  Faisal Zawawi; Alex M Mlynarek; Arielle Cantor; Rickul Varshney; Martin J Black; Michael P Hier; Louise Rochon; Richard J Payne
Journal:  J Otolaryngol Head Neck Surg       Date:  2013-12-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.